Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 05, 2021 at 04:16 pm EDT
Enzon Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was USD 291,000 compared to USD 8,000 a year ago. Operating loss was USD 21,000 compared to USD 236,000 a year ago. Net loss was USD 19,000 compared to USD 236,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, total revenue was USD 672,000 compared to USD 10,000 a year ago. Operating loss was USD 10,000 compared to USD 476,000 a year ago. Net loss was USD 8,000 compared to USD 478,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.